IL17A and type 2 diabetes mellitus: Meanwhile, the IL-17 signaling pathway of most immune cells in the BM was generally down-regulated under T2D conditions, which was reflected in the down-regulation of transcription factors and expression products of this pathway (Fig. 5E; Fig. S5).